Cytotoxic and genotoxic effects induced by stannous chloride associated to nuclear medicine kits

At present, more than 75% of routine nuclear medicine diagnostic procedures use technetium-99m ( 99mTc). The binding between 99mTc and the drug to obtain the radiopharmaceutical needs a reducing agent, with stannous chloride (SnCl 2) being one of the most used. There are controversies about the cyto...

Full description

Saved in:

Bibliographic Details
Published in:	Nuclear medicine and biology Vol. 33; no. 7; pp. 915 - 921
Main Authors:	Guedes, Anderson P., Cardoso, Valbert N., De Mattos, Jose C.P., Dantas, Flavio J.S., Matos, Vanessa C., Silva, Josiane C.F., Bezerra, Roberto J.A.C., Caldeira-de-Araujo, Adriano
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01-10-2006
Subjects:	Cell Survival - drug effects Cytotoxicity potentiality DNA, Bacterial - drug effects Dose-Response Relationship, Drug Escherichia coli Escherichia coli - cytology Escherichia coli - drug effects Escherichia coli - genetics Genotoxicity potentiality Mutagenicity Tests Mutation Nuclear Medicine - instrumentation Plasmid pUC 9.1 Radiopharmaceutical kits Reagent Kits, Diagnostic Stannous chloride Tin Compounds - administration & dosage Stannous chloride Genotoxicity potentiality Escherichia coli Cytotoxicity potentiality Plasmid pUC 9.1 Radiopharmaceutical kits
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	At present, more than 75% of routine nuclear medicine diagnostic procedures use technetium-99m ( 99mTc). The binding between 99mTc and the drug to obtain the radiopharmaceutical needs a reducing agent, with stannous chloride (SnCl 2) being one of the most used. There are controversies about the cytotoxic, genotoxic and mutagenic effects of SnCl 2 in the literature. Thus, the approaches below were used to better understand the biological effects of this salt and its association in nuclear medicine kits [methylenediphosphonate (MDP) bone scintigraphy and diethylenetriaminepentaacetic acid (DTPA) kidney and brain scintigraphy]: (i) bacterial inactivation experiments; (ii) agarose gel electrophoresis of supercoiled and linear plasmid DNA and (iii) bacterial transformation assay. The Escherichia coli strains used here were AB1157 (wild type) and BW9091 ( xthA mutant). Data obtained showed that both MDP and SnCl 2 presented a high toxicity, but this was not observed when they were assayed together in the kit, thereby displaying a mutual protect effect. DTPA salt showed a moderate toxicity, and once more, the DTPA kit provided protection, compared to the SnCl 2 effect alone. The results suggest a possible complex formation, either MDP-SnCl 2 or DTPA-SnCl 2, originating an atoxic compound. On the other hand, SnCl 2-induced cell inactivation and the decrease in bacterial transformation generated by DTPA found in XthA mutant strain suggest that the lack of this enzyme could be responsible for the effects observed, being necessary to induce DNA damage repair.
ISSN:	0969-8051 1872-9614
DOI:	10.1016/j.nucmedbio.2006.07.008